Cellionyx was founded on a singular mission: to engineer healing at the cellular level. After seeing the limitations of conventional therapies firsthand, Sanjay assembled a world-class team to build technology that works with the body's intelligence.
To revolutionize healing through precision bioelectric therapy, transforming how the medical community approaches tissue repair, pain management, and regenerative medicine by engineering solutions that work at the cellular level.
A world where every patient has access to advanced, non-invasive healing technologies that accelerate recovery, reduce pain, and restore function faster than ever thought possible.
Founder & CEO
Sanjay is a seasoned technology entrepreneur with 30+ years of global experience in innovation and venture development. He founded Equstech, where he developed the K2 device—a pioneering non-invasive bioelectric therapeutic tool for equine rehabilitation. His vision for Cellionyx stems from firsthand experience with bioelectric healing technology and a deep understanding of performance recovery needs across both human and veterinary applications.
Expertise: Bioelectric therapeutic technology, medical device development, venture leadership
Previous Ventures: Equstech (veterinary bioelectric devices), technology ventures in ERP/CRM solutions
Background: 30+ years global technology and innovation experience
Vision: Bringing proven bioelectric healing technology from veterinary success to human healthcare
Sanjay establishes Cellionyx with initial seed funding and begins developing core EDCMC technology.
Research and development focused on developing our proprietary wavelength technology and core EDCMC principles.
Continued R&D efforts developing our proprietary wavelength technology for optimal cellular regeneration.
Advanced R&D developing our proprietary wavelength technology with enhanced precision and efficacy.
Comprehensive testing and validation of Cytomotion™ technology across multiple clinical applications.
Refining and optimizing the Cytomotion™ device for enhanced performance and clinical outcomes.
Preparing for commercial launch with manufacturing scale-up and regulatory approval process.
World-class expertise across biomedical engineering, clinical research, regulatory affairs, and commercial operations.
Request a clinical demo to see how Cytomotion™ can integrate into your practice and revolutionize your approach to healing.